The state’s governor signed legislation to allow clinical trials of a psychedelic drug that shows promise for veterans in treating addiction and post-traumatic stress disorder.
Texas OK’s $50 Million for Ibogaine Research
Written by
in
Clinical Trials, Depression (Mental), Drugs (Pharmaceuticals), Food and Drug Administration, Ibogaine (drug), Law and Legislation, Mental Health and Disorders, Opioids and Opiates, Psychedelic and Hallucinogenic Drugs, Psychiatry and Psychiatrists, Regulation and Deregulation of Industry, Research, Texas, Therapy and Rehabilitation, Traumatic Brain Injury, United States Politics and Government, Veterans